Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

Clinical trial NCT01561456 · COMPLETED

Trial details

NCT number: NCT01561456
Sponsor: Axelar AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small-cell Lung Cancer Squamous Cell Carcinoma Adenocarcinoma of the Lung

Start date: 2011-12-01
Primary completion: 2013-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.